54° F
Feb
17
Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Roche Holding Limited

Highlights

A collection of news and information related to Roche Holding Limited published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 17
» View baltimoresun.com items only
    Feb 1, 2012 | Allentown Morning Call

  1. New help for basal cell skin cancer patients

    Health
    On Monday, the U.S. Food & Drug Administration approved a new drug to treat advanced basal cell carcinoma, the most common form of skin cancer. This is good news for the approximately 2.8 million Americans who will be diagnosed with a basal-cell...
    2. Jan 26, 2012 |Story| Los Angeles Times

  2. Amgen to buy Micromet for $1.6 billion for leukemia drug

    Amgen Inc., the world's largest biotechnology company, agreed to buy Micromet Inc. in a $1.16 billion deal to gain an experimental leukemia drug.
    Amgen Inc., the world's largest biotechnology company, agreed to buy Micromet Inc. in a $1.16 billion deal to gain an experimental leukemia drug. Investors of Micromet, based in Rockville, Maryland, will get $11 a share, the companies said in a statement...

    Tags: Deutsche Bank AG, Bloomberg L.P., Biotechnology Industry, Cancer, Hodgkin's lymphoma

    3. Jan 24, 2012 |Story| AP Broadcast

  3. Swiss drugmaker Roche opens $5.7 billion tender offer for DNA sequencing company Ilumina

    Swiss drugmaker Roche is offering shareholders $5.7 billion for DNA diagnostics company Ilumina. Roche Holding AG said in a statement early Wednesday that the deal will accelerate the routine clinical use of DNA testing. The company also said buying...

    Tags: Chemicals, Companies and Corporations, Human Body, Biotechnology Industry, DNA

    4. Aug 22, 2011 |Story| Reuters

  4. Seattle Genetics cancer drug price may top $100,000

    The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost.
    Reuters
    The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost. The U.S. Food and Drug Administration on Friday gave its nod to Adcetris, the first...

    Tags: Dendreon Corporation, Seattle Genetics Incorporated, Science, Blood, Washington, DC

    5. May 23, 2011 |Story| Reuters

  5. Vertex Hepatitis-C Drug OK'd, Promising More Cures

    Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co.
    Reuters
    Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co. Incivek, a pill...

    Tags: Vertex Pharmaceuticals Incorporated, Stock Market, New York Stock Exchange, John Wallace, Prices

    6. Dec 16, 2010 |Story| Hola Hoy
  6. |Story
    7. Dec 16, 2010 |Story| Hola Hoy
  7. |Story
    8. Mar 12, 2009 |Story| Associated Press

  8. Wall Street rallies after a day of good news; Dow logs biggest 3-day gain since November

    Investors have been clamoring for months for a bit of good news. On Thursday, they got a load of it. The Dow Jones industrials shot up 240 points to a two-week high of 7,170, bringing its gains over the past three days to 622 points, or 9.5 percent. It was the index's biggest three-day jump since last November.
    AP Business Writer
    Investors have been clamoring for months for a bit of good news. On Thursday, they got a load of it. The Dow Jones industrials shot up 240 points to a two-week high of 7,170, bringing its gains over the past three days to 622 points, or 9.5 percent. It...

    Tags: Bank of America Corp., Japan, Stock Market, Gilead Sciences Inc., Genentech Inc.

    9. Nov 7, 2009 |Story| Los Angeles Times

  9. New study may deal final blow to acne drug Accutane

    Teenagers and young adults suffering from severe, scarring acne may ultimately lose the most effective treatment for the condition.
    Teenagers and young adults suffering from severe, scarring acne may ultimately lose the most effective treatment for the condition. -------------------- FOR THE RECORD: Accutane's side effects: An article in Saturday's Section A about the possibility of...

    Tags: Pharmaceuticals, University of North Carolina at Chapel Hill, Colleges and Universities, Drugs and Medicines, Acne

    10. Jul 23, 2006 |Story| Tribune Media Services

  10. Cisco in position to capitalize on telecom growth

    Tribune Media Services columnist
    Q: I bought shares of Cisco Systems Inc. way back when they were booming. Are they coming back? -- C.G., via the Internet A: You can be confident that the dominant corporate networking company will in the long run benefit from the dramatic worldwide...

    Tags: Teva Pharmaceutical Industries Limited, Television Industry, SanDisk Corporation, Periodicals, Marketing

    11. Sep 17, 2006 |Story| Tribune Media Services

  11. Chip price war short-circuits gains at scrappy AMD

    Tribune Media Services columnist
    Q: What on earth has happened to my shares of Advanced Micro Devices Inc.? The bottom has fallen out. -- K.V., via the Internet A: Babe Ruth, the legend goes, once pointed to the bleachers before slamming a home run. Joe Namath guaranteed a Super Bowl...

    Tags: Dell Inc., H&R Block Inc., IBM, Cisco Systems Inc., Fannie Mae

    12. Feb 8, 2007 |Story| WGHP

  12. FDA Approves Non-Prescription Diet Pill

    Dieters got a new tool Wednesday to help them take off the extra pounds -- the first government-approved nonprescription diet pill.   The Food and Drug Administration said the fat-blocking weight-loss pill orlistat, which has been available by...

    Tags: Overweight, GlaxoSmithKline PLC, Diabetes, Skin Lesion, Diseases and Illnesses

 1  2 • Next >
Original site for Roche Holding Limited topic gallery.